AKR1C1 and lung carcinoma: Our analysis also indicated that the three members of the aldo-keto-reductase-1C (AKR1C) family (AKR1C1, AKR1C2, AKR1C3) correlated with resistance to GPX4 inhibitors in lung cancer CLs (Figure 6H).